Blue Cross Blue Shield Association
Based in DC
🤖
AI Overview
With $2.0M in lobbying spend across 25 quarterly filings, Blue Cross Blue Shield Association is a significant lobbying presence.
$2.0M
Total Lobbying Spend
25
Quarterly Filings
1
Lobbying Firms Used
3
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $160K |
| 2019 | $240K |
| 2020 | $290K |
| 2021 | $240K |
| 2022 | $240K |
| 2023 | $320K |
| 2024 | $160K |
| 2025 | $320K |
Lobbying Firms
AVENUE SOLUTIONS
What They Lobby For
- Implementation of healthcare and insurance market reform, including issues related to: -Health insurance exchanges - special enrollment periods, marketplace stability, grace periods, reinsurance, cost-sharing reductions, continuous coverage options; -Premium impact of ACA implementation; -ACA's health insurance tax; -Risk corridors and reinsurance; -Cost sharing reduction subsidies (CSRs); -Short term limited duration plans
- S. 1462, The Marketplace Certainty Act; S. 1354, The Individual Health Insurance Marketplace Improvement Act; S. 1201, The Healthcare Options for All Act; S. 1835, Lower Premiums Through Reinsurance Act of 2017; H.R. 4666, The Premium Relief Act; Cost sharing reduction subsidies, reinsurance and insurance market stabilization policies (Alexander-Murray proposal); Delay of health insurance tax
- Delay of health insurance tax
- S. 1462, The Marketplace Certainty Act; S. 1354, The Individual Health Insurance Marketplace Improvement Act; S. 1201, The Healthcare Options for All Act; S. 1835, Lower Premiums Through Reinsurance Act of 2017; H.R. 4666, The Premium Relief Act; Cost sharing reduction subsidies, reinsurance and insurance market stabilization policies (Alexander-Murray proposal); Delay of health insurance tax; Issues related to 42 CFR Part 2 - Confidentiality of Substance Use Disorder Patient Records
- Implementation of healthcare and insurance market reform, including issues related to: -Health insurance exchanges - special enrollment periods, marketplace stability, grace periods, reinsurance, cost-sharing reductions, continuous coverage options; -Premium impact of ACA implementation; -ACA's health insurance tax; -Cost sharing reduction subsidies (CSRs); -Short term limited duration plans (CRA); -Pre-existing conditions; -Surprise billing issues
- Cost sharing reduction subsidies, reinsurance and insurance market stabilization policies (Alexander-Murray proposal); Delay of health insurance tax; Monitor issues related to healthcare cost, surprise billing, and transparency; Issues realted the the Trump Administration's support for the Texas lawsuit that would rule the ACA unconstitutional; ACA stabilization: H.R. 1385, SAVE Act; H.R. 1386, H.R. 987, ENROLL Act of 2019; H.R. 1010, To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect; H.R. 986, Protecting Americans with Preexisting Conditions Act of 2019; H.R. 1425, State Health Care Premium Reduction Act
- Implementation of healthcare and insurance market reform, including issues related to: -Health insurance exchanges - special enrollment periods, marketplace stability, grace periods, reinsurance, cost-sharing reductions, continuous coverage options; -Premium impact of ACA implementation; -Cost sharing reduction subsidies (CSRs); -ACA's health insurance tax; -Short term limited duration plans (CRA); -Pre-existing conditions; -Surprise billing issues; Monitor Medicare for All discussions: H.R. 1384, Medicare for All Act of 2019/S. 1129, A bill to establish a Medicare-for-all national health insurance program
- Cost sharing reduction subsidies, reinsurance and insurance market stabilization policies; Alexander-Murray healthcare cost package: transparency, surprise billing; S. 1895, Lower Health Care Costs Act; S. 1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 3630, No Surprises Act; H.R. 3502, Protecting People From Surprise Medical Bills Act; H.R. 861, End Surprise Billing Act of 2019; All Payer Claims Database; Delay of health insurance tax; Issues related to the Trump Administration's support for the Texas lawsuit that would rule the ACA unconstitutional
- Implementation of healthcare and insurance market reform, including issues related to: -Health insurance exchanges - special enrollment periods, marketplace stability, grace periods, reinsurance, cost-sharing reductions, continuous coverage options; -Premium impact of ACA implementation; -Cost sharing reduction subsidies (CSRs); -ACA's health insurance tax; -Short term limited duration plans (CRA); -Pre-existing conditions; -Surprise billing issues; -Transparency: All-Payer Claims Database; Monitor Medicare for All discussions: H.R. 1384, Medicare for All Act of 2019; S 1129, Medicare for All Act of 2019
- Cost sharing reduction subsidies, reinsurance and insurance market stabilization policies; Alexander-Murray healthcare cost package: transparency, surprise billing; S. 1895, Lower Health Care Costs Act; S. 1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act - PCORI extension; H.R. 1865, Consolidated Domestic and International Assistance Bill; H.R. 3630, No Surprises Act; H.R. 3502, Protecting People From Surprise Medical Bills Act; H.R. 861, End Surprise Billing Act of 2019; All Payer Claims Database; Repeal of health insurance tax; Issues related to the Trump Administration's support for the Texas lawsuit that would rule the ACA unconstitutional; Protect practice of silver loading and auto enrollment in ACA exchanges
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.